Medipure Pharmaceuticals

📍 North Vancouver, Canada👥 4 employees💰 Last funded 2018
Pharmaceutical Manufacturing🌐 medipurepharmaceuticals.com
Website LinkedIn
Medipure Pharmaceuticals is a biopharmaceutical incubator committed to discovering and developing proprietary endocannabinoid system-based prescription drugs for targeted diseases by regulating specific molecular mechanisms. Our core products target specific disease areas including pain management, mood disorders/anxiety, nausea, appetite, oncology, arthritis and dermatology. Medipure Pharmaceuticals​ research and development is focused on having the greatest impact and benefit for patients worldwide. At the same time, we aim to make sure that our products are approved by regulators and well-understood by physicians, healthcare providers and prospective patients.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Medipure Pharmaceuticals?
Medipure Pharmaceuticals has 1 investors on record on gritt.io.
When did Medipure Pharmaceuticals last raise funding?
The most recent investment in Medipure Pharmaceuticals recorded on gritt.io was in 2018.
What industry is Medipure Pharmaceuticals in?
Medipure Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Medipure Pharmaceuticals based?
Medipure Pharmaceuticals is headquartered in North Vancouver, Canada.